Izhar Halahmi

Ellara Ltd. develops amorphous and nano-crystalline advanced material and solutions. It focuses on advanced heating products & coding for authentication and anti-shoplifting. The company was founded by Mark Geller and Eliezer Adar 1999 and is headquartered in Kfar Netter, Israel.

Cukierman & Co. Investment House Ltd. is an Israeli investment house founded in 1993 by Edouard Cukierman. The private company is based in Tel Aviv, Israel, and has subsidiaries in Israel and China. The Israeli company offers a range of services including M & A, Private Placements, Public Offerings, Family Office and Consulting Services to clients in Israel, Europe, and Asia.

LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel.

Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

BioProtect Ltd. designs, develops and commercializes balloon systems. Its patented technology allows for the design and manufacture of implantable biodegradable balloon products that support a wide range of clinical applications in oncology and surgery. The company’s balloon implant, indicated for prostate cancer patients. BioProtect was founded by Shaul Shohat, Adrian Paz and Abraham Domb in 2004 and is headquartered in Kfar Saba, Israel.

Medi-Tate Ltd. operates as a medical device company. It develops implantable medical devices for the treatment of benign prostate hyperplasia. The firm's product TIND, which designs to alleviate benign prostatic hyperplasia (BPH) symptoms. The company was founded by Ido Kilemnik in 2007 and is headquartered in Or Akiva, Israel.

Agate RM Investments & Medical Technologies Ltd. (Agate) is a venture capital firm founded in 2007 by Dani Naveh. The firm is headquartered in Tel Aviv, Israel.

NeuroQuest Ltd. develops biotechnology products. It offers biomarkers and diagnostic kits that use blood tests to detect Alzheimer's and Parkinson's diseases. The company was founded by Eti Yoles, Ishay Attar and Michal Schwartz in 2008 and is headquartered in M.P. Misgav, Israel.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

Omnix Medical Ltd. develops novel antibiotic agents against resistant pathogenic bacterial strains. The company was founded by Moshik Cohen-Kutner, Rekad Kheredin, Niv Bachnoff, and Rom Lakritz in 2015 and is headquartered in Jerusalem, Israel.

Matar Capital Advisors Ltd. provides financial and strategic advisory services. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Michel Moise Habib. Michel Moise Habib has been the CEO since incorporation.

OutSense Diagnostics Ltd. develops Internet on things sensors for wellness monitoring and the early detection of illness. Its sensors are designed to monitor essential health and wellness parameters and to communicate the data to a mobile app. The company was founded by Ishay Attar and is headquartered in Haifa, Israel.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Alive israel Healthtech Fund (Alive) is a venture capital firm founded in 2020 by Rafael Beyar, Michel Habib, Ari Shamiss and Dudi Klein. The firm is headquartered in Tel Aviv, Israel.